“Small Cap Biotech: Single Stock, Mutual Fund, or Small Cap Biotech ETF” (http://remonsy.com/
Portfolios of small cap biotech stocks are then covered. This option allows for more diversification than owning individual stocks. More diversification equates to more investing security, although it also means there’s less chance of experiencing explosive growth.
The article concludes with the investing opinion of Tom Vaughan, the CEO and founder of Remonsy ETF Network. Vaughan even shares a suggestion for a small cap biotech ETF to consider for a portfolio.
For do-it-yourself investors that want to learn about investing in different biotech stocks, visit the Remonsy ETF Network: http://remonsy.com/
Remonsy ETF Network publishes free daily tips, a daily newsletter and premium monthly reports based on Remonsy 5 Factor Investing: 1) Scientific Asset Allocation Models 2) Low cost ETF funds, 3) Tax-efficient investing, 4) opportunistic portfolio rebalancing and 5) Market timing doesn’t work. The company does not hold or manage funds, take commissions or receive any fees from investment companies.
About Remonsy and Tom Vaughan:
Tom Vaughan began his financial advisory career in 1987 at a Wall Street-based firm. In 1986, at the age of 23, he founded money management firm Retirement Capital Strategies. He is now taking his investment expertise from more than 26 years as an investment advisor with more than $300 million under management and over 6,000 financial plans created to launch Remonsy ETF Network. Remonsy investment advice focused around ETF funds will be delivered to the growing number of do-it-yourself investors through daily tips, free newsletters and premium products.